Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Brachytherapy in Treating Patients With Prostate Cancer

This study has been completed.
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Radiation Therapy Oncology Group Identifier:
First received: November 1, 1999
Last updated: January 23, 2014
Last verified: January 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2013
  Primary Completion Date: January 2004 (Final data collection date for primary outcome measure)
Lawton CA, DeSilvio M, Lee WR, et al.: Correlating prostate seed implant quality with clinical outcomes for patients treated on RTOG protocol 98-05 (a multi-institutional phase II trial of transrectal ultrasound guided prostate seed implant for localized prostate cancer). [Abstract] American Society of Clinical Oncology 2005 Prostate Cancer Symposium, 17-19 February 2005, Orlando, Florida. A-90, 2005.
Lawton CA, DeSilvio M, Lee WR, et al.: Results of a prospective multi-institutional phase II trial (RTOG 98-05) of transrectal ultrasound guided permanent radioactive implantation of the prostate for definitive management of localized adenocarcinoma of the prostate. [Abstract] Int J Radiat Oncol Biol Phys 60 (Suppl 1): A-90, S184, 2004.